Partnership

AbCellera is a privately held company that engages in partnerships to discover and develop next-generation therapeutic antibodies. Under the terms of the agreement with Novartis,…

Forbius is a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of fibrosis and cancer. It has entered into an collaboration…

Repare Therapeutics is pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in clearly defined patient populations.Ono…

Caelum Biosciences, founded by Fortress Biotech, Inc.(NASDAQ: FBIO) is a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. Alexion…

Invenra is a pre-clinical stage biopharmaceutical company focused on discovering biologics, with an emphasis on monoclonal antibodies (mAbs). The Wisconsin Alumni Research…

PellePharm is a biotechnology company committed to targeting rare dermatological diseases, including Gorlin Syndrome and Basal Cell Carcinomas, at the source. Under the agreement…

Kyn Therapeutics is a clinical-stage biotechnology company advancing new immunometabolic therapies for cancer. Kyn to receive $80 million upfront payment and an equity investment…

Elevian is an emerging biotech company developing medicines that restore youthful regenerative capacity, with the potential to treat and prevent the diseases of aging. Insilico…

Biogen is a leading neuro-focused biopharmaceutical company to work with Skyhawk on its STAR technology — “small molecule therapies for alternative splicing in RNA,  for the…

Biogen’s expertise in neuroscience and therapy development with C4T’s knowledge and research work into targeted protein degradation, to take up researching new potential therapies…